DrugCard

DrugCard is a modern software solution aimed at professionals responsible for monitoring the safety of medicinal products. Its primary function is to automate and enhance the process of screening medical literature, which is a critical requirement for pharmacovigilance activities in the pharmaceutical sector. By employing advanced artificial intelligence and robust optical character recognition, DrugCard is capable of scanning, extracting, and analyzing reports and studies published in a multitude of languages, making it adaptable for global compliance needs.

This platform provides a high degree of data accuracy, even working effectively on poorly scanned documents, and enables users to quickly adapt to new markets by integrating additional sources with minimal setup time. It is designed to minimize manual effort, significantly reducing the time and labor typically spent on reviewing scientific publications for safety signals. The transparency and traceability features aid organizations in maintaining a thorough audit trail, allowing for easier regulatory inspections and compliance management.

DrugCard offers substantial operational benefits for organizations of all sizes, ranging from individual consultants to large pharmaceutical companies. While it offers immediate gains in time and cost savings, there is an orientation phase to familiarize users with its advanced functionalities. The system is best suited for teams that require regular and comprehensive pharmacovigilance screening as part of their routine operations.

DrugCard is intended for pharmacovigilance professionals, regulatory affairs teams, and safety operations managers who are tasked with tracking and assessing drug safety through literature reviews. It is also highly relevant for Contract Research Organizations (CROs) and Marketing Authorization Holders (MAHs) who manage safety monitoring across diverse geographic regions and languages.

Freelance consultants and small teams working on pharmacovigilance projects will benefit from its automation capabilities, reducing the manual workload required for regular surveillance. Larger pharmaceutical companies and organizations responsible for ensuring ongoing regulatory compliance will find value in the platform's ability to support multi-market operations and supply a reliable audit trail for inspections or audits.

Academic researchers working in the field of drug safety and regulatory bodies preparing for audits or evaluations may use DrugCard to streamline the collection and analysis of multilingual safety data.